Search results
Results From The WOW.Com Content Network
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
An outbreak of measles was officially declared in February 2019 in select administrative regions in Luzon and Visayas including Metro Manila by the Philippine government. The outbreak is attributed to lower vaccination rates, from a high of 88% 10 to 15 years previous to 74% at the time of the outbreak, allegedly caused by the Dengvaxia ...
The Philippines is considering re-introducing a dengue vaccine whose use it halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has ...
In December 2018, Dengvaxia was approved in the European Union. [7]In May 2019, Dengvaxia was approved in the United States as the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3, and 4) in people ages nine through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas.
Pages in category "Health disasters in the Philippines" ... Dengvaxia controversy This page was last edited on 16 August 2020, at 17:29 (UTC). ...
This page was last edited on 25 December 2022, at 12:00 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Feb. 3—The U.S. military's continuing efforts to defuel and ultimately close the underground Red Hill fuel storage facility have sparked an unexpected controversy all the way in the Philippines ...
This page was last edited on 23 September 2021, at 18:18 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.